A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

New antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody ...

Monoclonal Antibodies IndustryThe global monoclonal antibodies (mAbs) industry, valued at USD 186 billion in 2021, is ...

NIH researchers identified MAD21-101, a novel antibody targeting a previously unexplored epitope on the malaria parasite.

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a ...

After a year that saw Ikena Oncology trim back its workforce and pipeline, the oncology biotech thinks it has found a ...

WuXi Biologics has signed a deal with Sino Biopharm to develop a first-in-class monoclonal antibody targeting an undisclosed ...

RAPT obtains worldwide rights excluding China - - Jemincare receives $35 million upfront payment, up to $672.5 million in milestone payments and high single-digit to low-double ...